VANCOUVER, BRITISH COLUMBIA--(Marketwire - August 29, 2008) - Pacgen Biopharmaceuticals Corporation (“Pacgen” or the “Company”) (TSX VENTURE: PGA) today reported financial results from its first fiscal quarter ended June 30, 2008. Amounts unless specified otherwise, are expressed in Canadian dollars and in accordance with Canadian Generally Accepted Accounting Principles (Canadian GAAP).
